It was when I went to take a shower and nearly passed out that I knew I was seriously sick. In October 2020 I had spent ...

Kayley Boda has undergone surgery to remove half of her right lung ...

SQ Innovation today announced topline results from the SUBCUT HF II trial of its product Lasix® ONYU, a novel subcutaneous formulation of furosemide for people with heart failure-associated edema.

Patient enrollment accelerates across expanding number of clinical trial sites in multiple countries 8 patients enrolled, with additional ...

Oral presentation to feature 99-patient dataset with extended follow-up in newly diagnosed NPM1-m or KMT2A-r AML –– High CRc rates (90–96%) ...

Kyowa Kirin and Kura Oncology Initiate Japanese Phase 2 Registration-Directed Trial of Ziftomenib in R/R NPM1-m AML ...

Tendai Ruben Mbofana The death of a loved one is an inherently agonizing experience, but when that passing is shrouded in systemic failure, administrative obfuscation, and a glaring lack of medical ...

University of Arizona Pulmonary Division Leads Landmark Clinical Study Evaluating Precision Epigenomics’ Pleural Fluid ...

Pleural effusion cytology is already used in cancer diagnosis, especially in metastatic settings, but its sensitivity can be limited. Tumor cells are easily masked by overwhelming numbers of ...

Tunnelling workers’ health and lives are at risk from the continued refusal of corporations and government authorities to ...

YZYBIO-B (02496.HK) 0.000 (0.000%) announced that the New Drug Application (NDA) for its self-developed bispecific antibody ...

KOMZIFTI (ziftomenib) net product revenue in first full quarter of commercialization - - Robust new patient starts and early launch dynamics, including repeat use, switching and combination ...